186 related articles for article (PubMed ID: 36801152)
41. Leu-M1 antigen expression in acute leukaemias.
de Mascarel A; Coindre JM; de Mascarel I; David B; Trojani M; Broustet A
J Pathol; 1987 Nov; 153(3):225-32. PubMed ID: 3501459
[TBL] [Abstract][Full Text] [Related]
42. Molecular Pathogenesis of Peripheral T Cell Lymphoma.
Sakata-Yanagimoto M; Chiba S
Curr Hematol Malig Rep; 2015 Dec; 10(4):429-37. PubMed ID: 26431836
[TBL] [Abstract][Full Text] [Related]
43. Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.
Jiang M; Bennani NN; Feldman AL
Expert Rev Hematol; 2017 Mar; 10(3):239-249. PubMed ID: 28133975
[TBL] [Abstract][Full Text] [Related]
44. Cutaneous Lymphoma at Injection Sites: Pathological, Immunophenotypical, and Molecular Characterization in 17 Cats.
Roccabianca P; Avallone G; Rodriguez A; Crippa L; Lepri E; Giudice C; Caniatti M; Moore PF; Affolter VK
Vet Pathol; 2016 Jul; 53(4):823-32. PubMed ID: 26933095
[TBL] [Abstract][Full Text] [Related]
45. Lymphoma cytogenetics.
Dave BJ; Nelson M; Sanger WG
Clin Lab Med; 2011 Dec; 31(4):725-61, x-xi. PubMed ID: 22118746
[TBL] [Abstract][Full Text] [Related]
46. Malignant lymphomas of the skin: their differentiation from lymphoid and nonlymphoid cutaneous infiltrates that simulate lymphoma.
Burke JS
Semin Diagn Pathol; 1985 Aug; 2(3):169-82. PubMed ID: 3916553
[TBL] [Abstract][Full Text] [Related]
47. Cellular differentiation markers in lymphoproliferative diseases.
Siegal FP
Hosp Pract; 1978 Oct; 13(10):79-89. PubMed ID: 310413
[TBL] [Abstract][Full Text] [Related]
48. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.
Boerma EG; Siebert R; Kluin PM; Baudis M
Leukemia; 2009 Feb; 23(2):225-34. PubMed ID: 18923440
[TBL] [Abstract][Full Text] [Related]
49. Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.
Bogusz AM; Bagg A
Leuk Lymphoma; 2016 Sep; 57(9):1991-2013. PubMed ID: 27121112
[TBL] [Abstract][Full Text] [Related]
50. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
51. Pathology of primary cutaneous B-cell lymphomas: diagnosis and classification.
Hsi ED
Clin Lymphoma; 2004 Sep; 5(2):89-97. PubMed ID: 15453923
[TBL] [Abstract][Full Text] [Related]
52. Characterization of posttransplant lymphomas that express T-cell-associated markers: immunophenotypes, molecular genetics, cytogenetics, and heterotransplantation in severe combined immunodeficient mice.
Waller EK; Ziemianska M; Bangs CD; Cleary M; Weissman I; Kamel OW
Blood; 1993 Jul; 82(1):247-61. PubMed ID: 8100721
[TBL] [Abstract][Full Text] [Related]
53. Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level.
Chung C
J Oncol Pharm Pract; 2020 Jun; 26(4):943-966. PubMed ID: 31964218
[TBL] [Abstract][Full Text] [Related]
54. Ontogeny, Genetics, Molecular Biology, and Classification of B- and T-Cell Non-Hodgkin Lymphoma.
Ryan RJH; Wilcox RA
Hematol Oncol Clin North Am; 2019 Aug; 33(4):553-574. PubMed ID: 31229154
[TBL] [Abstract][Full Text] [Related]
55. Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markers.
Bergmann L; Mitrou PS; Cherdron T; Holloway K; Jost J; Timm V; Zerth G
Scand J Haematol; 1982 Sep; 29(3):224-34. PubMed ID: 6983113
[TBL] [Abstract][Full Text] [Related]
56. Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis.
Kanungo A; Medeiros LJ; Abruzzo LV; Lin P
Mod Pathol; 2006 Jan; 19(1):25-33. PubMed ID: 16258503
[TBL] [Abstract][Full Text] [Related]
57. Pathology of peripheral T-cell lymphomas and leukemias.
Watanabe S
Hematol Oncol; 1986; 4(1):45-58. PubMed ID: 2939016
[TBL] [Abstract][Full Text] [Related]
58. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
Griesser DH
Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
[TBL] [Abstract][Full Text] [Related]
59. Cytogenetics in malignant lymphomas.
Kaneko Y
Curr Opin Oncol; 1990 Oct; 2(5):816-21. PubMed ID: 2095886
[No Abstract] [Full Text] [Related]
60. Diagnostic and prognostic molecular pathology of lymphoid malignancies.
Fend F; van den Brand M; Groenen PJ; Quintanilla-Martinez L; Bagg A
Virchows Arch; 2024 Feb; 484(2):195-214. PubMed ID: 37747559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
